Press Releases - 2020-01-22

Date	Title	Company
22-Jan-2020	New Coastal Group Launches Endo-Aligned(TM) CBD Tinctures and Softgels for Targeted Support	newcoastal.shop
22-Jan-2020	The Center for Breakthrough Medicines is Building the World's Largest Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) to Launch in King of Prussia, PA	The Discovery Labs
22-Jan-2020	Neurotrope, Inc. Announces $18 Million Registered Direct Offering	Neurotrope, Inc.
22-Jan-2020	US Kidney Dialysis Center Revenues to Advance 4.9% Annually in Nominal Dollars to 2023	The Freedonia Group
22-Jan-2020	KALY - Kali-Extracts Confirms Puration Talks in Strategy to Consolidate on $50 Million Cannabis Biopharmaceutical Technology Business	Kali-Extracts, Inc.; Puration, Inc.
22-Jan-2020	Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020	Society for Science & the Public
22-Jan-2020	Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020	Regeneron Pharmaceuticals, Inc.
22-Jan-2020	Creek Mountain Partners Responds To Generex Statements	Creek Mountain Partners
22-Jan-2020	Contract research firm set to double in size following Northern VCT investment	Gentronix Ltd
22-Jan-2020	Freeline to present further FLT180a data at EAHAD	Freeline
22-Jan-2020	Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund	Seekyo
22-Jan-2020	Myeloma UK London Paris Ride 2020 Launch	Myeloma UK
22-Jan-2020	Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update	Hansa Biopharma
22-Jan-2020	Alliance Pharma PLC - Full Year Trading Update	Alliance Pharma plc
22-Jan-2020	TISSIUM Recognized as a French Tech 120 Company	TISSIUM
22-Jan-2020	Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions	Toxys
22-Jan-2020	Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa	Abeona Therapeutics
22-Jan-2020	Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease	Novartis
22-Jan-2020	Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis	Polaryx Therapeutics, Inc
22-Jan-2020	PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease	PredictImmune